Wang, Xueqi <br/><br/>
Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.  [electronic resource] 

 -  Kidney international  Nov 2013 
 - 962-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1038/ki.2013.199  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albuminuria--metabolism<br/>Animals<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Disease Progression<br/>Diuresis--drug effects<br/>Dose-Response Relationship, Drug<br/>Glycosuria--metabolism<br/>Heterozygote<br/>Ki-67 Antigen--metabolism<br/>Kidney--drug effects<br/>MAP Kinase Signaling System--drug effects<br/>Male<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Molecular Targeted Therapy<br/>Phlorhizin--pharmacology<br/>Polycystic Kidney Diseases--drug therapy<br/>Rats<br/>Sodium-Glucose Transport Proteins--antagonists & inhibitors<br/>Time Factors<br/>Urological Agents--pharmacology